Evidence map›Paper›PMID 41358267›Full record

ReviewmicroLife2025

The

Chloé Dugelay, Jean Celli, Laurent Terradot

Abstract readReview
In one paragraph

Review in microLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Virulence · 2026
    Article
  2. Article
  3. Review
  4. Exploring the Link Between Biotin Metabolism andPathogens (Basel, Switzerland) · 2026
    Article
  5. Review
  6. OralFrontiers in microbiology · 2026
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chloé DugelayLaboratory of Molecular Microbiology and Structural Biochemistry, UMR 5086, CNRS - Université de Lyon, Institut de Biologie et Chimie des Protéines, 7, passage du Vercors, Lyon 69007, France.
Jean CelliDepartment of Microbiology and Molecular Genetics, Larner College of Medicine at the University of Vermont, 95 Carrigan Drive, Burlington 05405 VT, USA.
Laurent TerradotLaboratory of Molecular Microbiology and Structural Biochemistry, UMR 5086, CNRS - Université de Lyon, Institut de Biologie et Chimie des Protéines, 7, passage du Vercors, Lyon 69007, France.ORCID https://orcid.org/0000-0003-4279-9167

Funding

Remodeling of intracellular membrane traffic by Brucella effectorsR01AI158372 · NIAID · WASHINGTON STATE UNIVERSITY · PI JEAN A CELLI · 2022 to 2026
$3.0M
Structure and functions of a bacterial Type IV effector complexR21AI185853 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CELLI, JEAN A · 2024 to 2025
$390k
NIAID NIH HHS R01 AI158372NIAID NIH HHS R21 AI185853
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bacterial secretion systemBrucellaeffectorgram-negativeintracellular pathogenvirulence factor

Identifiers

PMID41358267
PMCPMC12676571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.